10 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

MMSphere

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

DEFINITIVE, FLEXLENS - SILICONE HYDROGEL

FDA 510(k)
FDA Class 2 ·Ophthalmic

PLANET 55, MODEL 100

FDA 510(k)
FDA Class 2 ·Cardiovascular

SYNCHRO2-14 SUPPORT STRAIGHT 215CM

FDA Adverse Event
Malfunction ·STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY·Product code DQX·December 14, 2023

DR. SCHOLL'S FREEZE AWAY COMMON & PLANTAR WART REMOVER

FDA Adverse Event
Malfunction ·Product code GEH·June 21, 2013

ACCOLADE 5.5 PLUS

FDA Adverse Event
Malfunction ·STRYKER ORTHOPAEDICS CORK·Product code MEH·October 2, 2008

XPRT SLEEP SURFACE

FDA Adverse Event
Injury ·STRYKER CORP DBA GAYMAR·Product code INX·July 29, 2011

BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER

FDA Adverse Event
Malfunction ·BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.·Product code FOZ·August 29, 2019

Stryker T2 Arthrodesis Nailing System. Manufacturer: Stryker Trauma GmbH, Professor-Kuntscher-Str. 1-5, 24232 Schonkirchen Germany. Distributed in the USA by Stryker Orthopaedics, 325 Corporate Drive, Mahwah, NJ 07430. The T2 Arthrodesis Nail is intended for the treatment of Knee Arthrodesis. The design of the T2 Arthrodesis Nail features a unique curvature which incorporates both femur ante curvature and knee valgus bend. Indications: Aseptic failed total knee arthro-plasty with or without bone loss; Failed external fixation, non unions and malunions; Periarticular fractures where repair is not possible; Pathologic fractures and tumor resections; Pseudoarthrosis and correct osteotomy; Ipsilateral femur fractures; and Open and closed femoral fractures.

FDA Enforcement
Class II ·Terminated·Stryker Howmedica Osteonics Corp.·July 25, 2012

Exactech Equinoxe REVERSE SHOULDER,36mm Humeral Liner: a) +0mm, Item Number 320-36-00, b) +2.5mm, Item Number 320-36-03; Shoulder Arthroplasty

FDA Enforcement
Class II ·Ongoing·Exactech, Inc.·April 10, 2024